Drug and Therapeutics Bulletin 1995;33:62-64; doi:10.1136/dtb.1995.33862
Copyright © 1995 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Benzamycin gel for acne

Relevant BNF section: 13.6.1

Benzamycin gel (Bioglan Laboratories), a combined formulation of 5% benzoyl peroxide and 3% erythromycin, was launched in the UK last year as a topical treatment for acne vulgaris. Its constituents are often prescribed together for the treatment of mild or moderate acne, usually one to be applied in the morning and the other at night. Does the combined preparation (which is expensive) have any advantages over separate preparations of benzoyl peroxide and erythromycin used concurrently?






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1995 BMJ Publishing Group Ltd.